Page 68 - Read Online
P. 68

Page 12 of 14                                  Schwertheim et al. Hepatoma Res 2020;6:41  I  http://dx.doi.org/10.20517/2394-5079.2020.23


               and in both the cytosol and the nucleus; they suppose that methylation/demethylation plays a role in
               modulating β-catenin activity. Henderson et al. described that β-catenin can be exported from the nucleus
                                                                     [29]
               to the cytoplasm where its levels are regulated by degradation . Our results suggest that methylation of
               β-catenin by KDM2A and consequently, repressing of Wnt/β-catenin signaling might play a role in the
               beneficial survival of patients with immunopositive inclusions and cytoplasm. However, mechanistically
               driven experiments are necessary to prove this hypothesis. The role of KDM2A in disease is contradictory
                                                                                          [30]
                                             [26]
               and seems to be context dependent . On one hand, KDM2A is upregulated in ovarian , breast and lung
                                                                                                        [32]
               cancer [13,30,31]  and associated with a poor prognosis; on the other, it is downregulated in prostate cancer
               and in the liver, KDM2A regulates hepatic gluconeogenesis whereby its exogenous expression reduces
                                [33]
               blood glucose levels . Reasons for the dual effects of KDM2A may be due to the involvement of KDM2A
               in various biological signaling pathways, including interacting with the p53-binding protein and NF-
                                                                        [34]
               kappaB activity by demethylation of the p65 subunit of NF-kappaB . Further, we found that the increased
               occurrence of NI was significantly associated with KDM2A immunopositivity in NI. KDM2A is described as
                                                                [32]
               a heterochromatin-associated and HP1-interacting protein  and KDM2A is required to sustain centromeric
                                                                  [32]
               integrity and genomic stability, particularly during mitosis . A change in chromatin stability has been
               discussed as a factor contributing to the development of NI [6,16,35,36] . Thus, we suppose that KDM2A might
               play a role in the formation of inclusions. The mechanisms that participate in the formation of inclusions are
               still poorly understood, in spite of several investigations [35,37] . However, we believe that various factors can
               induce the formation of inclusions and that KDM2A may be one.

               In this study, we demonstrated accumulations of β-catenin and proteins associated with the Wnt/β-catenin
               pathway in NI. The simultaneous presence of β-catenin with autophagy-associated proteins, partly co-
               localized to the same inclusion suggests that biological processes similar to autophagy might take place in
               NI. Further, we found that the presence of KDM2A immnuopositive NI provides a survival benefit to HCC
               patients. To what extent this is related to possible degradation of β-catenin by KDM2A, and whether NI play
               a role in these biological processes needs to be analyzed by further experiments.

               DECLARATIONS
               Acknowledgments
               We thank Dorothe Möllmann (Institute of Pathology, University Hospital of Essen, University of Duisburg-
               Essen) for her excellent technical assistance. Additionally, the authors thank Laura Malkus (Institute of
               Pathology, University Hospital of Essen, University of Duisburg-Essen) for technical assistance in the
               preparation of the samples for TEM.

               Authors’ contributions
               Made substantial contributions to conception and design of the study and performed data analysis and
               interpretation: Schwertheim S, Baba HA, Jastrow H, Herold T
               Conceptualization: Schwertheim S, Baba HA, Schmid KW
               Data acquisition: Herold T, Jastrow H, Baba HA, Schmid KW
               Investigation: Schwertheim S, Theurer S, Jastrow H, Herold T, Ting S, Kälsch J, Baba HA, Schmid KW
               Methodology: Schwertheim S, Theurer S, Jastrow H, Herold T, Ting S, Kälsch J, Baba HA
               Supervision: Schwertheim S, Baba HA, Schmid KW
               Writing - original draft preparation: Schwertheim S, Baba HA
               Writing - review and editing: Schwertheim S, Theurer S, Jastrow H, Herold T, Ting S, Kälsch J, Baba HA,
               Schmid KW

               Availability of data and materials
               The source of the data came from the Institute of Pathology, University Hospital of Essen.
   63   64   65   66   67   68   69   70   71   72   73